Search for: "Ranbaxy Laboratories Ltd."
Results 21 - 40
of 70
Sort by Relevance
|
Sort by Date
8 Jul 2012, 1:58 pm
Five big U.S. retailers filed an antitrust lawsuit against Pfizer Inc and India's Ranbaxy Laboratories Ltd on Thursday, accusing them of conspiring to delay sales of generic versions of Lipitor, the best-selling drug in history. [read post]
27 Jun 2012, 5:38 am
As we previously reported, back in 2010, Caraco Pharmaceutical Laboratories, Ltd. [read post]
29 Dec 2011, 12:35 am
According to the company’s announcement: Ranbaxy Laboratories Ltd. [read post]
28 Dec 2011, 2:09 pm
Image via Wikipedia Last week, India’s largest drug manufacturer, Ranbaxy Laboratories Ltd., announced that it had entered into a consent decree with the Food and Drug Administration (FDA) and had set aside a provision of $500 million to cover any liability arising out of a separate investigation by the Department of Justice (DOJ). [read post]
5 Dec 2011, 10:00 am
Ranbaxy Laboratories Ltd. has gained approval to make generic atorvastatin calcium tablets in 10 milligram, 20 mg, 40 mg, and 80 mg strengths. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
10 May 2011, 11:59 pm
Reddy's Laboratories that will enable a generic version of Effexor XR to enter the market on June 1, 2011. [read post]
29 Dec 2010, 2:57 am
Highlights this week included: CAFC: Broad scope of statutory subject matter: Prometheus Laboratories, Inc. v. [read post]
17 Nov 2010, 1:48 am
Highlights this week included: Efexor (Venlafaxine) – Australia: Federal Court blocks generic Efexor-XR: Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth Australia Pty Ltd (Patentology) (BAZPAT) (GenericsWeb) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
6 Oct 2010, 11:43 pm
Teva appealed the decision arguing that the case should proceed, and the Federal Circuit agreed applying a 2008 decision in Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
6 Oct 2010, 4:31 pm
With respect to the jurisdictional issue, the court focused on two cases: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
18 Aug 2010, 12:19 am
Ranbaxy Laboratories Ltd. et al. [read post]
8 Aug 2010, 8:32 pm
• Defendants: Ranbaxy Laboratories Ltd.; Ranbaxy Pharmaceuticals Inc.; Ranbaxy, Inc.; Ethypharm S.A. [read post]
28 Jul 2010, 12:06 am
Ranbaxy Laboratories Inc. [read post]
16 Jun 2010, 3:02 pm
Ranbaxy Laboratories Ltd. et al. [read post]
19 May 2010, 6:15 am
Norbrook Laboratories Ltd et al. [read post]
13 May 2010, 4:58 pm
Ltd. et al. v. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals Industries Ltd. et al. [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al v Abbott… [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al v Abbott… [read post]
